Reuters logo
BRIEF-Exonics therapeutics raises $40 million in series A financing
November 8, 2017 / 12:53 PM / 11 days ago

BRIEF-Exonics therapeutics raises $40 million in series A financing

Nov 8 (Reuters) - Exonics Therapeutics:

* Exonics therapeutics raises $40 million in series a financing

* Exonics therapeutics​ - ‍secured a $40 million series a financing to advance its lead gene editing program in Duchenne from column

* Exonics therapeutics​ - also announced TCG’s David Goeddel, managing partner, and JJ Kang, principal, will be joining company’s board Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below